Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted18F-DCFPyL positron emission tomography/computed tomography: A unique visual pattern

被引:2
作者
Yin, Yafu [1 ,4 ]
Paller, Channing J. [2 ]
Pomper, Martin G. [1 ,2 ,3 ]
Pienta, Kenneth J. [2 ,3 ]
Gorin, Michael A. [1 ,2 ,3 ]
Rowe, Steven P. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sidney Kimmell Comprehens Canc Ctr, Dept Oncol, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD USA
[4] China Med Univ, Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China
基金
美国国家卫生研究院;
关键词
18F-DCFPyL; positron emission tomography; computed tomography; prostate cancer; prostate-specific membrane; vas deferens;
D O I
10.4103/wjnm.WJNM_50_18
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
New radiotracers for positron emission tomography imaging that target prostate-specific membrane antigen (PSMA) have emerged as important clinical tools for imaging prostate cancer (PCa). PSMA-targeted radiotracers have demonstrated high sensitivity and high specificity for detecting sites of PCa and are demonstrably superior to conventional imaging modalities such as computed tomography and bone scan. Vas deferens invasion is a rarely encountered poor prognostic feature of PCa. In this case report, we describe a novel pattern of radiotracer uptake in a patient with PCa imaged with PSMA-targeted18F-DCFPyL positron emission tomography/computed tomography that is consistent with diffuse vas deferens involvement.
引用
收藏
页码:424 / 427
页数:4
相关论文
共 50 条
  • [21] Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
    Bodar, Yves J. L.
    Veerman, Hans
    Meijer, Dennie
    de Bie, Katelijne
    van Leeuwen, Pim J.
    Donswijk, Maarten L.
    van Moorselaar, R. Jeroen A.
    Hendrikse, N. Harry
    Boellaard, Ronald
    Oprea-Lager, Daniela E.
    Vis, Andre N.
    BJU INTERNATIONAL, 2022, 129 (06) : 768 - 776
  • [22] Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model
    Alvim, Ricardo
    Nagar, Karan
    Das, Sudeep
    Lebdai, Souhil
    Wong, Nathan
    Somma, Alexander
    Hughes, Christopher
    Thomas, Jasmine
    Monette, Sebastien
    Scherz, Avigdor
    Kim, Kwanghee
    Grimm, Jan
    Coleman, Jonathan A.
    EUROPEAN UROLOGY FOCUS, 2021, 7 (02): : 472 - 478
  • [23] Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
    Natarajan, Aravintho
    Agrawal, Archi
    Murthy, Vedang
    Bakshi, Ganesh
    Joshi, Amit
    Purandare, Nilendu
    Shah, Sneha
    Puranik, Ameya
    Rangarajan, Venkatesh
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2019, 18 (03) : 244 - 250
  • [24] 68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis
    von Eyben, Finn E.
    Picchio, Maria
    von Eyben, Rie
    Rhee, Handoo
    Bauman, Glenn
    EUROPEAN UROLOGY FOCUS, 2018, 4 (05): : 686 - 693
  • [25] Radiographic and metabolic evolution of prostate cancer lung metastasis detected by prostate-specific membrane antigen and fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography
    Tsakiridis, Theodoros
    Bonert, Michael
    Zukotynski, Katherine
    Anagnostopoulos, Alexander Efstathios
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2020, 19 (04) : 421 - 424
  • [26] The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer
    Koschel, Samantha
    Murphy, Declan G.
    Hofman, Michael S.
    Wong, Lih-Ming
    CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 569 - 577
  • [27] The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
    Luining, Wietske I.
    Hagens, Marinus J.
    Meijer, Dennie
    Ringia, Joanneke B.
    de Weijer, Tessa
    Bektas, Huseyyin O.
    Ettema, Rosemarijn H.
    Knol, Remco J. J.
    Roeleveld, Ton A.
    Srbljin, Sandra
    Weltings, Saskia
    Koppes, Jose C. C.
    Moorselaar, Reindert J. A. van
    van Leeuwen, Pim J.
    Oprea-Lager, Daniela E.
    Vis, AndreN.
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 59 : 55 - 62
  • [28] Role of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging
    Kesch, Claudia
    Franiel, Tobias
    Berliner, Christoph
    Fendler, Wolfgang P.
    Herrmann, Ken
    Hadaschik, Boris
    UROLOGIE, 2025, : 220 - 228
  • [29] Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
    Udovicich, Cristian
    Callahan, Jason
    Bressel, Mathias
    Ong, Wee Loon
    Perera, Marlon
    Tran, Ben
    Azad, Arun
    Haran, Shankar
    Moon, Daniel
    Chander, Sarat
    Shaw, Mark
    Eapen, Renu
    Goad, Jeremy
    Lawrentschuk, Nathan
    Murphy, Declan G.
    Hofman, Michael
    Siva, Shankar
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 44 : 60 - 68
  • [30] Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
    Gorin, Michael A.
    Rowe, Steven P.
    Patel, Hiten D.
    Vidal, Igor
    Mana-ay, Margarita
    Javadi, Mehrbod S.
    Solnes, Lilja B.
    Ross, Ashley E.
    Schaeffer, Edward M.
    Bivalacqua, Trinity J.
    Partin, Alan W.
    Pienta, Kenneth J.
    Szabo, Zsolt
    De Marzo, Angelo M.
    Pomper, Martin G.
    Allaf, Mohamad E.
    JOURNAL OF UROLOGY, 2018, 199 (01) : 126 - 132